Boswellia Serrata Extract
Supports Joint Health & Mobility*
In contrast to NSAIDS for chronic conditions Boswellia does not inhibit prostaglandin production.
Inhibits 5-lipoxygenase, decreasing leukotriene synthesis.
Mechanism of action: Animal studies performed in India show that BSE (Boswellia Serrata Extract) decreased polymorphonuclear leukocyte infiltration and migration, decreased antibody synthesis and caused almost total inhibition of classical complement pathway. Recently, BSE has been shown to inhibit 5-lipoxygenase and also human leukocyte elastase and as a result been proposed in the treatment of various inflammatory conditions (1). The mechanism of action is quite distinct from non-steroidal anti-inflammatory drugs (NSAIDS) which inhibit prostaglandin synthesis.
Each Softgel Contains:
| Boswellia Serratta Extract (WokVel®) | 333 | mg |
| Standardized to contain minimum 65% organic acids or 40% total Boswellic acids |
Several clinical studies confirm the benefits of BSE in supporting healthy joint function and optimizing gastrointestinal and respiratory health.
References 1. Sharma S, Thawani V, Hingorani L et al. Pharmokinetic study of 11-Keto Beta-Boswellic Acid. Phytomedicine 2004; 11: 255-60
WokVel® is a licensed trademark of Verdure Sciences.
| *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. |
